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Introduction
Juvenile idiopathic arthritis (JIA) is one of the most
common rheumatic disease in children.
Brug of choice is methotrexate (MTX) - cytostatic drug
from the group of antimetabolites, folic acid antagonists.
According to various authors, about 70% of patients
receiving therapy with MTX are in remission for the
disease.
In 1988, MTX was approved FDA (Food and Drug
Administration, USA) for the treatment of rheumatoid
arthritis. Currently, MTX is the main drug in the treat-
ment of JIA. Preferred therapeutic recommendations on
the number of MTX based on a randomized, double-
blind, placebo-controlled study conducted in 1992.
MDR1-gene product - the P-glycoprotein (P-gp), the
protein acts as a trans-membrane pump, and affects the
activity of many drugs. Polymorphism in the gene MDR1,
may affect the pharmacokinetics of many drugs, including
anticancer drugs.
According to the authors of Jinwei Chen (2011) in
adult patients with rheumatoid arthritis (RA) in the Chi-
nese population C3435T MDR1 gene polymorphism may
be associated with susceptibility to RA, but may influence
the effectiveness of antirheumatic therapy of RA, and CC
genotype may be associated with immune rheumatoid
arthritis (RRA).
Objectives
The aim of our study is to determine the effect on the effi-
ciency of the MDR1 gene therapy JIA.
Methods
Were examined 103 patients diagnosed with juvenile idio-
pathic arthritis (according to the EULAR), receiving stan-
dard treatment with methotrexate at a dose of 15 mg/m2
over 3 months (intramuscular). All children were defined
P-glycoprotein (the product of the gene MDR1), and
C3435T polymorphism of the gene MDR1. A genetic
study was carried out using polymerase chain reaction fol-
lowed by restriction analysis to determine the C3435T
polymorphism of the gene MDR1. Modeling inflammation
in vitro was carried out by treating the blood with recom-
binant human interleukin 2, followed by determination of
the level of P-glycoprotein (CD243-PE) on peripheral
blood lymphocytes with monoclonal antibodies by flow
cytofluorometry.
Results
Among the 103 children included in the study - 65
(63.11%) females and 38 (36.89%) boys with different
forms of juvenile idiopathic arthritis: polyarthritis - 46
children (44.66%), oligoarthritis - 25 children (24, 27%),
systemic arthritis - 14 children (13.59%), arthritis entezi-
tassociated - 18 patients (17.48%).
Analysis of changes in the level of P-glycoprotein after
IL2 stimulation, depending on the genotype of MDR1
gene showed significant differences. When comparing
the patients in these groups, it was found that in the
group of children with genotype TT, increase P-IL2 pro-
tein after stimulation were significantly lower than in
children with genotype CT. In patients with genotype TT
average sedimentation rate was significantly higher than
that of children in the group CT in the acute phase, and
in the waning activity of the inflammatory process in the
joints. Similar changes were obtained by comparing the
genotypes CC + CT and TT.
Conclusion
Given the data, we can assume that children with the TT
genotype MDR1 gene (C3435T) is worse respond to stan-
dard treatment of JIA.
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